Nordic Nanovector ASA News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.08.17	Nordic Nanovector ASA - Resultater for Andre Kvartal Og Første Halvår 2017 (PR Newswire)
23.08.17	Nordic Nanovector ASA - Resultater for Andre Kvartal Og Første Halvår 2017 (PR Newswire)
14.08.17	Nordic Nanovector to Host Capital Markets Day in Oslo on 22 November 2017 (PR Newswire)
14.08.17	Nordic Nanovector to Host Capital Markets Day in Oslo on 22 November 2017 (PR Newswire)
10.08.17	Nordic Nanovector to Present at Wedbush PacGrow Healthcare Conference (PR Newswire)
10.08.17	Nordic Nanovector to Present at Wedbush PacGrow Healthcare Conference (PR Newswire)
02.08.17	Nordic Nanovector Appoints Dr. Reza Safaei as Head of Medical Affairs (PR Newswire)
02.08.17	Nordic Nanovector Appoints Dr. Reza Safaei as Head of Medical Affairs (PR Newswire)
10.07.17	Nordic Nanovector ASA: Increase of Share Capital/Mandatory Notification of Trade (PR Newswire)
10.07.17	Nordic Nanovector ASA: Increase of Share Capital/Mandatory Notification of Trade (PR Newswire)
05.07.17	Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider (PR Newswire)
05.07.17	Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider (PR Newswire)
22.06.17	Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider (PR Newswire)
19.06.17	Nordic Nanovector to Present to Investors at the Citi European Healthcare Conference (PR Newswire)
19.06.17	Nordic Nanovector to Present to Investors at the Citi European Healthcare Conference (PR Newswire)
14.06.17	Single Dose Betalutin® Continues to Show Promising Efficacy and Safety in Recurrent Indolent NHL Patients (PR Newswire)
13.06.17	Nordic Nanovector - Invitation to Conference Call for Updated Clinical Trial Results Reported at the International Conference on Malignant Lymphoma (PR Newswire)
13.06.17	Nordic Nanovector - Invitation to Conference Call for Updated Clinical Trial Results Reported at the International Conference on Malignant Lymphoma (PR Newswire)
09.06.17	Nordic Nanovector to be Included in Oslo Børs OBX Index (PR Newswire)
09.06.17	Nordic Nanovector to be Included in Oslo Børs OBX Index (PR Newswire)
07.06.17	Accepted Abstract by ICML With Updated Results From Phase 1/2 Trial of Betalutin® in NHL is Now Available On-line (PR Newswire)
07.06.17	Accepted Abstract by ICML With Updated Results From Phase 1/2 Trial of Betalutin® in NHL is Now Available On-line (PR Newswire)
02.06.17	Nordic Nanovector ASA: Allocation of Restricted Stock Units (RSUs) to the Board of Directors (PR Newswire)
02.06.17	Nordic Nanovector ASA: Allocation of Restricted Stock Units (RSUs) to the Board of Directors (PR Newswire)
02.06.17	Nordic Nanovector to Present at Jefferies Healthcare Conference in New York on Thursday, June 8th (PR Newswire)
24.05.17	Nordic Nanovector ASA: Annual General Meeting Held (PR Newswire)
24.05.17	Nordic Nanovector ASA: Annual General Meeting Held (PR Newswire)
24.05.17	Nordic Nanovector ASA - Results for First Quarter 2017 (PR Newswire)
24.05.17	Nordic Nanovector ASA - Results for First Quarter 2017 (PR Newswire)
24.05.17	Nordic Nanovector ASA - resultater for første kvartal 2017 (PR Newswire)
19.05.17	Safety Review Committee Approves the Continued Evaluation of the 20 MBq/kg Betalutin® with 100 mg/m2 Lilotomab Regimen in Phase 2 Cohort in NHL (PR Newswire)
19.05.17	Safety Review Committee Approves the Continued Evaluation of the 20 MBq/kg Betalutin® with 100 mg/m2 Lilotomab Regimen in Phase 2 Cohort in NHL (PR Newswire)
02.05.17	Nordic Nanovector ASA: Notice of Annual General Meeting on 24 May 2017 (PR Newswire)
28.04.17	Updated Results from Phase 1/2 Trial of Betalutin® in NHL Accepted for Presentation at the International Conference on Malignant Lymphoma in June (PR Newswire)
28.04.17	Updated Results from Phase 1/2 Trial of Betalutin® in NHL Accepted for Presentation at the International Conference on Malignant Lymphoma in June (PR Newswire)
27.04.17	Nordic Nanovector to Present at Upcoming Deutsche Bank and Jefferies Healthcare Conferences (PR Newswire)
27.04.17	Nordic Nanovector to Present at Upcoming Deutsche Bank and Jefferies Healthcare Conferences (PR Newswire)
27.03.17	Nordic Nanovector ASA - Financial Calendar (PR Newswire)
24.03.17	Nordic Nanovector Publishes Annual Report 2016 (PR Newswire)
24.03.17	Nordic Nanovector Publishes Annual Report 2016 (PR Newswire)
17.03.17	Nordic Nanovector Announces First Patient Dosed in Phase 1 Study of Betalutin® in Diffuse Large B-cell Lymphoma (DLBCL), an Aggressive Form of NHL (PR Newswire)
17.03.17	Nordic Nanovector Announces First Patient Dosed in Phase 1 Study of Betalutin® in Diffuse Large B-cell Lymphoma (DLBCL), an Aggressive Form of NHL (PR Newswire)
28.02.17	Nordic Nanovector ASA - Results for Fourth Quarter and Full Year 2016 (PR Newswire)
28.02.17	Nordic Nanovector ASA - Results for Fourth Quarter and Full Year 2016 (PR Newswire)
28.02.17	Nordic Nanovector ASA - resultater for fjerde kvartal og helår 2016 (PR Newswire)
22.02.17	Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2016 Results Presentation and Webcast (PR Newswire)
02.02.17	Nordic Nanovector ASA: Share Capital Increase Registered (PR Newswire)
02.02.17	Nordic Nanovector ASA: Share Capital Increase Registered (PR Newswire)
02.02.17	Nordic Nanovector: Share Options Granted, Including Options to Primary Insiders (PR Newswire)
24.01.17	Nordic Nanovector ASA: Exercise of Employee Share Options and Increase of Share Capital (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Nordic Nanovector ASA

Aktien Top/Flop

Meistgelesene Nachrichten